Cytiva · 6 hours ago
Senior Financial Analyst, Hardware Solutions Ops, Duncan
Cytiva, a Danaher operating company, is dedicated to transforming human health through innovative solutions in life sciences and biotechnology. The Senior Financial Analyst will provide financial support and business partnership to the Operations team, focusing on cost management, inventory, and capital expenditures.
Responsibilities
Inventory: Excess and Obsolete Inventory analysis (actuals and forecast), Blocked Stock provision, Forecasting alignment with Materials leader, Monthly actuals reporting/turns calculations, Cycle count coordination, design levels review and assisting in analysis of scrap, scrap DoA adherence
Fixed Asset Management: Annual Fixed asset PI Coordination, Idle asset reporting, Capital allocation request support, tracking “AUC Assets under Construction spend, aging CIP follow ups FAR Asset creation / tagging support and impairment reviews
Open PO and works order review, ensuring timely closure at month end
Providing Site Accounts Payable support; Resolving Supplier Stops and Invoice holds etc
Compliance: SOX testing and review to ensure site always remains compliant
Qualification
Required
Bachelor's degree in related with 3-5 years of experience working in a manufacturing facility in Operations finance OR Master's degree in field with 3+ years experience
Solid PC skills: experience with financial systems/applications (e.g. SAP), strong Excel skills in data compilation and aggregation (i.e. pivot tables, vlookups etc)
Attention to detail is a must
Tenacious approach to problem solving
Flexible approach and able to work with associates from various functions within the business
Ability to travel – on occasions, overnight, within US
Must have a valid driver's license with an acceptable driving record
Preferred
Power BI
SAP and Oracle
Benefits
Paid time off
Medical/dental/vision insurance
401(k)
Company
Cytiva
Cytiva, now with the life sciences business from Pall Corporation, is a global biotechnology leader dedicated to helping customers discover and commercialize the next generation of therapeutics.
Funding
Current Stage
Late StageLeadership Team
Recent News
2025-10-14
Company data provided by crunchbase